Avity Investment Management Inc. Cuts Stake in GE HealthCare Technologies Inc. $GEHC

Avity Investment Management Inc. lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 91.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,300 shares of the company’s stock after selling 112,745 shares during the quarter. Avity Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $774,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the stock. Dodge & Cox boosted its stake in GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. Norges Bank purchased a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $468,120,000. Capital Research Global Investors raised its holdings in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Boston Partners purchased a new position in GE HealthCare Technologies in the third quarter valued at approximately $287,627,000. Finally, Holocene Advisors LP lifted its stake in GE HealthCare Technologies by 178.5% in the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on GEHC. Piper Sandler raised their target price on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Jefferies Financial Group lifted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Barclays boosted their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Friday, February 6th. Finally, Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Trading Up 0.2%

NASDAQ:GEHC opened at $72.34 on Wednesday. The company has a market cap of $32.97 billion, a P/E ratio of 15.86, a P/E/G ratio of 1.59 and a beta of 1.03. The stock’s fifty day moving average price is $80.24 and its two-hundred day moving average price is $78.52. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period last year, the company earned $1.45 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is presently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.